Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 2
1988 1
1989 3
1990 2
1991 5
1992 5
1993 7
1994 3
1995 2
1996 3
1997 1
1998 5
1999 4
2000 7
2001 13
2002 14
2003 17
2004 23
2005 25
2006 41
2007 62
2008 55
2009 67
2010 90
2011 108
2012 117
2013 127
2014 174
2015 200
2016 241
2017 250
2018 296
2019 307
2020 433
2021 446
2022 519
2023 595
2024 220

Text availability

Article attribute

Article type

Publication date

Search Results

4,002 results

Results by year

Filters applied: . Clear all
The following term was ignored: %
The following term was not found in PubMed: 20Yuan
Page 1
Retraction.
[No authors listed] [No authors listed] J Cell Physiol. 2022 Nov;237(11):4327. doi: 10.1002/jcp.30893. Epub 2022 Oct 20. J Cell Physiol. 2022. PMID: 36264182
Retraction: "Long noncoding RNA LINC00152 promotes cell growth and invasion of papillary thyroid carcinoma by regulating the miR-497/BDNF axis," by Zhihui Sun, Xun Guo, Mingcui Zang, Peisong Wang, Shuai Xue, and Guang Chen, J Cell Physiol. 2019; 1336-1345: The above articl …
Retraction: "Long noncoding RNA LINC00152 promotes cell growth and invasion of papillary thyroid carcinoma by regulating the miR-497/BDNF ax …
AUTHOR REPLY.
Yuanzhuo C, Liao P, Chi Z, Shuai X, Deyi L. Yuanzhuo C, et al. Urology. 2023 Jan;171:95. doi: 10.1016/j.urology.2022.08.051. Urology. 2023. PMID: 36610785 No abstract available.
Integrating network pharmacology and experimental validation to decipher the mechanism of the Chinese herbal prescription modified Shen-Yan-Fang-Shuai formula in treating diabetic nephropathy.
Yu B, Zhou M, Dong Z, Zheng H, Zhao Y, Zhou J, Zhang C, Wei F, Yu G, Liu WJ, Liu H, Wang Y. Yu B, et al. Pharm Biol. 2023 Dec;61(1):1222-1233. doi: 10.1080/13880209.2023.2241521. Pharm Biol. 2023. PMID: 37565668 Free PMC article.
CONTEXT: Diabetic nephropathy (DN) is the main cause of end-stage renal disease. Modified Shen-Yan-Fang-Shuai formula (M-SYFSF) has excellent clinical efficacy in treating diabetic kidney disease. ...
CONTEXT: Diabetic nephropathy (DN) is the main cause of end-stage renal disease. Modified Shen-Yan-Fang-Shuai formula (M-SYFSF) has e …
CircRNAs and LncRNAs in Osteoporosis.
He T, Liu W, Cao L, Liu Y, Zou Z, Zhong Y, Wang H, Mo Y, Peng S, Shuai C. He T, et al. Differentiation. 2020 Nov-Dec;116:16-25. doi: 10.1016/j.diff.2020.10.002. Epub 2020 Oct 28. Differentiation. 2020. PMID: 33157509 Review.
Macromolecules and Antibody-Based Drugs.
Su XD, Shuai Y. Su XD, et al. Adv Exp Med Biol. 2020;1248:485-530. doi: 10.1007/978-981-15-3266-5_20. Adv Exp Med Biol. 2020. PMID: 32185723 Review.
Shen-Shuai-II-Recipe inhibits tubular inflammation by PPARalpha-mediated fatty acid oxidation to attenuate fibroblast activation in fibrotic kidneys.
Wang M, Wang L, Zhou L, Xu Y, Wang C. Wang M, et al. Phytomedicine. 2024 Apr;126:155450. doi: 10.1016/j.phymed.2024.155450. Epub 2024 Feb 12. Phytomedicine. 2024. PMID: 38368794
BACKGROUND: Shen Shuai Recipe (SSR) is clinically used to treat chronic kidney diseases (CKDs) with remarkable efficacy and safety. ...
BACKGROUND: Shen Shuai Recipe (SSR) is clinically used to treat chronic kidney diseases (CKDs) with remarkable efficacy and safety. . …
A versatile genetic tool: haploid cells.
Li Y, Shuai L. Li Y, et al. Stem Cell Res Ther. 2017 Sep 29;8(1):197. doi: 10.1186/s13287-017-0657-4. Stem Cell Res Ther. 2017. PMID: 28962667 Free PMC article. Review.
4,002 results